Showing all posts written by David Dremann
According to the Deal Book, the Jewish Voice, and a Covidien press release, Covidien will acquire all outstanding shares of Given Imaging Ltd. in a transaction valued at $860 million. Covidien has agreed to a purchase price of $30.00
Regulatory approval of medical devices is a significant consideration for any innovator or manufacturer of medical technologies. The U.S. FDA’s regulatory approval processes, including, for example, 510(k) clearances and PMA
Medical device development, as always, is shooting upwards – and it has just reached the clouds.
As a self-diagnosed autophile (defined by wikitionary as “an automobile enthusiast”) and amateur grease monkey living in So Cal, I am a firm believer in the therapeutic powers of an internal combustion engine.
News Medical reports that on July 17, 2013, China-based medical device developer and manufacturer Mindray Medical International Limited completed the acquisition of Mountain View, California-based ZONARE Medical Systems, Inc. Under
4-traders reports that Pleasanton, California-based Thoratec Corporation has acquired the DuraHeart II ventricular assist system from Tokyo-based Terumo Corporation for up to $43.5M. The deal has been structured such that Thoratec
According to Daily Finance’s Investor Center and a press release from Techne Corporation, medical device manufacturer Techne Corporation is set to acquire a 100% ownership stake in Devens, Massachusetts-based Bionostics
On Monday, June 3, 2013, the Federal Circuit affirmed the judgments of non-infringement and invalidity in a lawsuit filed by the University of Minnesota against AGA Medical. The opinion was authored by Judge Dyk.
The University of Minnesota
News Medical reports that Seattle, Washington-based NeuroVista and professors at the University of Melbourne, led by Professor Mark Cook have collaborated to successfully develop and test in humans a device potentially capable of predicting
According to the press release,
Angiotech announced this morning that it has entered into an agreement to sell its Interventional Products business line for $362.5 million in cash to Argon Medical Devices, Inc. According to the press release, the sale is expected to close
HD Medical, Inc. announced today the launch of its business operations in the United States and its flagship product, the “ViScope Visual Stethoscope.” According to the press release, the stethoscope features:
NewsMedical reports that the FDA has approved Second Sight Medical Products’ Argus II Retinal Prosthesis System, an implanted device to treat patients with advanced retinitis pigmentosa. According to the story:
a small video